Michael Day

Michael Day is an accomplished professional in the field of regulatory science and pharmaceutical consulting with extensive experience spanning over two decades. Currently serving as the Vice President of Regulatory Science and Cell & Gene Therapy Lead at Voisin Consulting Life Sciences (VCLS) since November 2018, Michael previously held significant roles at Cardinal Health Regulatory Sciences, including Director of Chemistry, Manufacturing, and Controls, and Managing Director at Cardinal Health. Michael's expertise also includes consultancy positions with Beckloff Associates and a foundational role as a Staff Chemist at Midwest Research Institute. Michael holds a Ph.D. in Pharmaceutical Science and Chemistry from the University of Missouri-Kansas City and a B.S. in Chemistry and Biology from Rockhurst University.